Search

Recent progress in molecular engineering, digital imaging and artificial intelligence improve human modern medicine to levels never seen before. Digital pathology becomes the new standard of patient care in dermatology and personalized medicine. It is increasingly used for digital exchange of histological slides, personalized consultations, tumor boards, quantitative image analysis for research purposes and in education. Digital pathology allows automatization and quantification with greater consistency and accuracy than light microscopy. Personalized dermatology is focusing on tailoring therapy to the individual characteristics of each patient and allow to use genetic information in order to develop a treatment plan, uniquely suited to each patient, which in turn leads to improved quality of care and management of each individual., Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article. Le laboratoire de DH profite d’un contrat scientifique de la part d’Unilabs.

These guidelines for the management of congenital ichthyoses have been developed by a multidisciplinary group of European experts following a systematic review of the current literature, an expert conference held in Toulouse in 2016, and a consensus on the discussions. These guidelines summarize evidence and expert-based recommendations and intend to help clinicians with the management of these rare and often complex diseases. These guidelines comprise two sections. This is part two, covering the management of complications and the particularities of some forms of congenital ichthyosis., (© 2018 British Association of Dermatologists.)

These guidelines for the management of congenital ichthyoses have been developed by a multidisciplinary group of European experts following a systematic review of the current literature, an expert conference held in Toulouse in 2016 and a consensus on the discussions. They summarize evidence and expert-based recommendations and are intended to help clinicians with the management of these rare and often complex diseases. These guidelines comprise two sections. This is part one, covering topical therapies, systemic therapies, psychosocial management, communicating the diagnosis and genetic counselling., (© 2018 British Association of Dermatologists.)

Progress in paediatric dermatology is achieved in both research and therapeutic fields. In infectiology, scabies and bed bugs are a scourge for dermatologists, with an important recent outbreak. This article describes the fundamental clinical signs to look for, when suspecting such diagnosis. Hair dermatoscopy seems to be also very precious as a new tool for the diagnosis of ringworm. Regarding eczemas, atopic dermatitis is supported by S. Aureus's skin colonization, the target of eradication of new products in ongoing studies. We will also explain the role of Hemangiol, recently marketed in Switzerland for the treatment of haemangiomas. Alternative beta blockers have also a large number of ongoing projects in the dermatological vascular diseases field. Other various news is to be discovered....

Discusses abstracts of research papers presented during the 29th annual general meeting of the North of England Dermatology Society and the Scottish Dermatological Society on June 4-5, 1999. Association between melanocortin 1 receptor gene and hair color; Identification of mutations associated with Darier's disease; Link between mutations in the gap junction protein connexin 26 and palmoplantar keratoderma and deafness.

The article discusses a study of five European families with a clinical diagnosis of punctate palmoplantar keratoderma type (PPPK 1) of Buschke-Fischer-Brauer type, an autosomal dominant disorder of keratinization. Topics discussed include the clinical manifestations PPK1, identification of heterozygous nonsense mutation within the GTPase domain of the p34 protein and haploin-sufficiency in subjects consistent with the increase in cell proliferation in PPPK lesions.

Presents a letter to the editor commenting on novel mutation of connexin 31 causing erythrokeratoderma variabilis.